Novel Glucagon-like Peptide-1 Receptor Agonists: A Comprehensive Review
Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a valuable class of drugs in the management of type 2 diabetes mellitus. These agents replicate the actions of naturally occurring GLP-1, promoting insulin secretion and reducing glucagon release. Recent research have yielded a extensive range of novel GLP-1 receptor agonists with en